de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Impressum Kontakt Einloggen
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Structure and Functionality of a Designed p53 Dimer.

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons83876

Davison,  TS
Department Empirical Inference, Max Planck Institute for Biological Cybernetics, Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Davison, T., Nie X, Ma W, Lin Y, Kay C, Benchimol, S., & Arrowsmith, C. (2001). Structure and Functionality of a Designed p53 Dimer. Journal of Molecular Biology, 307(2), 605-617. Retrieved from http://www.sciencedirect.com/science?_ob=ArticleURL_udi=B6WK7-457D1FN-7V_coverDate=032F232F2001_alid=279790610_rdoc=1_fmt=_orig=search_qd=1_cdi=6899_sort=dview=c_acct=C000003178_version=1_urlVersion=0_userid=29041md5=10f0441c8e1d885a0c584.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0013-E2CE-B
Zusammenfassung
P53 is a homotetrameric tumor suppressor protein involved in transcriptional control of genes that regulate cell proliferation and death. In order to probe the role that oligomerization plays in this capacity, we have previously designed and characterized a series of p53 proteins with altered oligomeric states through hydrophilc substitution of residues Met340 or Leu344 in the normally tetrameric oligomerization domain. Although such mutations have little effect on the overall secondary structural content of the oligomerization domain, both solubility and the resistance to thermal denaturation are substantially reduced relative to that of the wild-type domain. Here, we report the design and characterization of a double-mutant p53 with alterations of residues at positions Met340 and Leu344. The double-mutations Met340Glu/Leu344Lys and Met340Gln/Leu344Arg resulted in distinct dimeric forms of the protein. Furthermore, we have verified by NMR structure determination that the double-mutant Met340Gln/Leu344Arg is essentially a "half-tetramer". Analysis of the in vivo activities of full-length p53 oligomeric mutants reveals that while cell-cycle arrest requires tetrameric p53, transcriptional transactivation activity of monomers and dimers retain roughly background and half of the wild-type activity, respectively.